Exhibit 99.1

		news

		FOR IMMEDIATE RELEASE
INVESTOR CONTACT:		MEDIA CONTACT:
Mark Kimbrough		Ed Fishbough
615-344-2688		615-344-2810

HCA Reports Third Quarter 2010 Results
Net Income Attributable to HCA Inc. Increases 24.3 Percent

Nashville, Tenn., November 9, 2010 — HCA Inc. today announced financial and operating results for its third quarter ended September 30, 2010.

Key third quarter metrics (all percentage changes compare 3Q 2010 to 3Q 2009 unless noted):

	•		Revenues increased 1.5 percent to $7.647 billion — cash revenues increased 4.6 percent to $6.926 billion.
	•		Net income attributable to HCA Inc. totaled $243 million, an increase of 24.3 percent
	•		Adjusted EBITDA increased 6.6 percent to $1.357 billion, a 90 basis point improvement in margin to 17.8 percent
	•		Cash revenue per equivalent admission increased 4.1 percent
	•		Cash flows from operations increased $219 million to $1.260 billion
	•		Same facility equivalent admissions increased 0.7 percent while same facility admissions declined 0.6 percent
	•		Surgeries on a same facility basis declined 2.1 percent

Third quarter of 2010 results improved due to a continued focus on revenue growth and operational efficiencies. Same facility equivalent admissions increased 0.7 percent in the third quarter of 2010, compared to the prior year, reflecting both inpatient and outpatient volumes. Same facility admissions declined 0.6 percent, reflecting reduced deliveries and a difficult comparison due to high H1N1 flu volumes in the third quarter of 2009. Same facility emergency room visits increased 1.2 percent in the third quarter of 2010 compared to an increase of 11.1 percent in the third quarter of 2009 which was primarily the result of the H1N1 flu volumes.

Revenues in the third quarter increased 1.5 percent to $7.647 billion compared to $7.533 billion in the third quarter of 2009. Cash revenues totaled $6.926 billion compared to $6.623 billion, an increase of 4.6 percent, compared to the prior year’s third quarter. Cash revenues is a non-GAAP measure and reflects the Company’s reported revenues less the provision for doubtful accounts (bad debts). Revenue growth was driven by increased volume, revenue per equivalent admission and patient acuity, which increased 2.7 percent in the quarter compared to the prior

year. Net income attributable to HCA Inc. totaled $243 million compared to $196 million in the third quarter of 2009. Adjusted EBITDA increased 6.6 percent in the quarter to $1.357 billion compared to $1.273 billion in the prior year. Tables describing adjusted EBITDA and cash revenues and reconciling net income attributable to HCA Inc. to adjusted EBITDA, and reported revenues to cash revenues, are included in this release. Results in the third quarter of 2010 include impairments of long-lived assets of $10 million and losses on sale of facilities of $2 million compared to impairments of long-lived assets of $3 million in the third quarter of 2009.

“We believe our solid performance this year is due to effective execution of our operating strategies, which are centered on improvements in clinical care, patient service and operating efficiencies. We continue to invest in those strategies that advance these agendas,” stated Richard M. Bracken, Chairman of the Board and Chief Executive Officer of HCA.

The Company’s provision for doubtful accounts declined to $721 million, or 9.4 percent of revenues, in the third quarter of 2010, compared to $910 million, or 12.1 percent of revenues, in the same period of 2009. This decline is primarily due to a $476 million increase in charity care and uninsured discounts in the third quarter. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of revenues, uninsured discounts and charity care, was 26.4 percent for the third quarter of 2010, compared to 24.9 percent for the third quarter of 2009. Same facility uninsured admissions increased 3.9 percent in the third quarter compared to the prior year and comprised 7.4 percent of total admissions compared to 7.1 percent in the third quarter of 2009.

During the third quarter of 2010, salaries and benefits, supplies and other operating expenses totaled $5.636 billion, or 73.7 percent of revenues (81.4 percent of cash revenues), compared to $5.403 billion, or 71.7 percent of revenues (81.6 percent of cash revenues), in the third quarter of 2009.

Nine Months Ended September 30, 2010

Revenues for the nine months ended September 30, 2010 totaled $22.947 billion compared to $22.447 billion in the same period of 2009. Net income attributable to HCA Inc. was $924 million for the nine month period of 2010, an increase of 10.3 percent, compared to $838 million in the previous year. Adjusted EBITDA totaled $4.421 billion compared to $4.129 billion in 2009. Results for the nine months of 2010 include impairments of long-lived assets of $119 million and losses on sales of facilities of $2 million compared to impairments of long-lived assets of $16 million and losses on sales of facilities of $8 million for the nine month period of 2009.

As of September 30, 2010, HCA’s balance sheet reflected cash and cash equivalents of $377 million, total debt of $26.079 billion, and total assets of $23.253 billion. During the third quarter of 2010, capital expenditures totaled $324 million and for the first nine months of 2010 they totaled $860 million. Net cash provided by operating activities in the third quarter totaled $1.260 billion compared to $1.041 billion in the prior year’s third quarter. Through September 30, 2010, net cash provided by operating activities totaled $2.611 billion compared to $2.315 billion for the same period of 2009. As of September 30, 2010, HCA had in excess of $2.1 billion of liquidity under its senior secured revolving credit facilities.

As of September 30, 2010 HCA operated 162 hospitals and 104 freestanding surgery centers (including eight hospitals and eight free standing surgery centers operated through equity method joint ventures).

Hospital Acquisitions

On November 1, 2010, St. David’s Healthcare System, a partnership between HCA and the St. David’s Foundation, completed the acquisition of The Heart Hospital of Austin located in Austin, TX. Also, Methodist Healthcare System, a partnership between HCA and the Methodist Healthcare Ministries, has entered into a definitive agreement to purchase substantially all of the assets of Texsan Heart Hospital in San Antonio, TX with closing expected during the first quarter of 2011.

Proposed Distribution to Stockholders

It is contemplated that, subject to applicable legal and contractual restrictions, during the fourth quarter of 2010, an approximate $2 billion distribution will be declared to the Company’s existing stockholders and holders of vested stock options. A portion of such distribution would be funded using funds available under the Company’s existing senior secured revolving credit facilities. The balance of such distribution, if any, would be funded with proceeds from new indebtedness contemplated to be incurred by a newly-created holding company. There can be no assurance that the incurrence of such indebtedness and related holding company restructuring and distribution will be completed. The Company’s leverage ratio as of September 30, 2010, as measured by the ratio of long-term debt to adjusted EBITDA, was 4.52x. On a pro forma basis, to reflect the contemplated distribution and related indebtedness, the Company’s estimated leverage ratio would be 4.88x for the same date.

Earnings Conference Call

HCA will host a conference call for investors at 9:00 a.m. Central Standard Time today. All interested investors are invited to access a live audio broadcast of the call via webcast. The broadcast also will be available on a replay basis beginning this afternoon. The webcast can be accessed at: http://www.talkpoint.com/viewer/starthere.asp?Pres=133103

or through the Company’s Investor Relations web page, www.hcahealthcare.com.

Cautionary Statement about Preliminary Results and Other Forward-Looking Information

This press release contains forward-looking statements based on current management expectations. Those forward-looking statements include all statements other than those made solely with respect to historical fact. Numerous risks, uncertainties and other factors may cause actual results to differ materially from those expressed in any forward-looking statements. These factors include, but are not limited to, (1) the ability to recognize the benefits of the recapitalization, (2) the impact of the substantial indebtedness incurred to finance the recapitalization and distributions and proposed distributions to stockholders and the ability to refinance such indebtedness on acceptable terms, (3) the effects related to the enactment of federal health care reform, the possible enactment of additional federal or state health care reform and possible changes to health care reform and other federal, state or local laws or

regulations affecting the health care industry, (4) increases, particularly during periods of economic slowdown, in the amount and risk of collectability of uninsured accounts and deductibles and copayment amounts for insured accounts, (5) the ability to achieve operating and financial targets, and attain expected levels of patient volumes and control the costs of providing services, (6) possible changes in the Medicare, Medicaid and other state programs, including Medicaid supplemental payments pursuant to upper payment limit (“UPL”) programs, that may impact reimbursements to health care providers and insurers, (7) the highly competitive nature of the health care business, (8) changes in revenue mix, including potential declines in the population covered under managed care agreements and the ability to enter into and renew managed care provider agreements on acceptable terms, (9) the efforts of insurers, health care providers and others to contain health care costs, (10) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, (11) increases in wages and the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical and technical support personnel, (12) the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities, (13) changes in accounting practices, (14) changes in general economic conditions nationally and regionally in our markets, (15) future divestitures which may result in charges and possible impairments of long-lived assets, (16) changes in business strategy or development plans, (17) delays in receiving payments for services provided, (18) the outcome of pending and any future tax audits, appeals and litigation associated with our tax positions, (19) potential liabilities and other claims that may be asserted against us, and (20) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2009 and other filings with the Securities and Exchange Commission. Many of the factors that will determine our future results are beyond our ability to control or predict. In light of the significant uncertainties inherent in the forward-looking statements contained herein, readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

HCA Inc.
Condensed Consolidated Income Statements
Third Quarter
(Dollars in millions)

		2010								2009
		Amount				Ratio				Amount				Ratio
Revenues		$	7,647				100.0	%		$	7,533				100.0	%
Salaries and benefits			3,134				41.0				3,013				40.0
Supplies			1,234				16.1				1,206				16.0
Other operating expenses			1,268				16.6				1,184				15.7
Provision for doubtful accounts			721				9.4				910				12.1
Equity in earnings of affiliates			(67	)			(0.9	)			(53	)			(0.7	)
Depreciation and amortization			352				4.7				354				4.7
Interest expense			525				6.9				510				6.8
Losses on sales of facilities			2				—				—				—
Impairments of long-lived assets			10				0.1				3				—
			7,179				93.9				7,127				94.6
Income before income taxes			468				6.1				406				5.4
Provision for income taxes			143				1.9				132				1.8
Net income			325				4.2				274				3.6
Net income attributable to noncontrolling interests			82				1.0				78				1.0
Net income attributable to HCA Inc.		$	243				3.2			$	196				2.6

HCA Inc.
Condensed Consolidated Income Statements
For the Nine Months Ended September 30, 2010 and 2009
(Dollars in millions)

		2010								2009
		Amount				Ratio				Amount				Ratio
Revenues		$	22,947				100.0	%		$	22,447				100.0	%
Salaries and benefits			9,282				40.4				8,880				39.6
Supplies			3,685				16.1				3,627				16.2
Other operating expenses			3,696				16.1				3,410				15.1
Provision for doubtful accounts			2,073				9.0				2,583				11.5
Equity in earnings of affiliates			(210	)			(0.9	)			(182	)			(0.8	)
Depreciation and amortization			1,062				4.7				1,067				4.8
Interest expense			1,571				6.8				1,487				6.6
Losses on sales of facilities			2				—				8				—
Impairments of long-lived assets			119				0.5				16				0.1
			21,280				92.7				20,896				93.1
Income before income taxes			1,667				7.3				1,551				6.9
Provision for income taxes			488				2.2				480				2.1
Net income			1,179				5.1				1,071				4.8
Net income attributable to noncontrolling interests			255				1.1				233				1.1
Net income attributable to HCA Inc.		$	924				4.0			$	838				3.7

HCA Inc.
Supplemental Non-GAAP Disclosures
Operating Results Summary
(Dollars in millions)

										For the Nine Months
		Third Quarter								Ended September 30,
		2010				2009				2010				2009
Revenues		$	7,647			$	7,533			$	22,947			$	22,447
Net income attributable to HCA Inc.		$	243			$	196			$	924			$	838
Losses on sales of facilities (net of tax)			1				—				1				5
Impairments of long-lived assets (net of tax)			6				2				75				10
Net income attributable to HCA Inc., excluding losses on sales of facilities and impairments of long-lived assets (a)			250				198				1,000				853
Depreciation and amortization			352				354				1,062				1,067
Interest expense			525				510				1,571				1,487
Provision for income taxes			148				133				533				489
Net income attributable to noncontrolling interests			82				78				255				233
Adjusted EBITDA (a)		$	1,357			$	1,273			$	4,421			$	4,129

HCA Inc.
Supplemental Non-GAAP Disclosures
Operating Measures on a Cash Revenues Basis
Third Quarter
(Dollars in millions)

		2010												2009
						Non-GAAP												Non-GAAP
						% of Cash				GAAP % of								% of Cash				GAAP % of
						Revenues				Revenues								Revenues				Revenues
		Amount				Ratios (b)				Ratios (b)				Amount				Ratios (b)				Ratios (b)
Revenues		$	7,647								100.0			$	7,533								100.0
Provision for doubtful accounts			721												910
Cash revenues (a)			6,926				100.0								6,623				100.0
Salaries and benefits			3,134				45.2				41.0				3,013				45.5				40.0
Supplies			1,234				17.8				16.1				1,206				18.2				16.0
Other operating expenses			1,268				18.4				16.6				1,184				17.9				15.7
% changes from prior year:
Revenues			1.5	%
Cash revenues			4.6
Revenue per equivalent admission			1.1
Cash revenue per equivalent admission			4.1

HCA Inc.
Supplemental Non-GAAP Disclosures
Operating Measures on a Cash Revenues Basis
For the Nine Months Ended September 30, 2010 and 2009
(Dollars in millions)

		2010												2009
						Non-GAAP												Non-GAAP
						% of Cash				GAAP % of								% of Cash				GAAP % of
						Revenues				Revenues								Revenues				Revenues
		Amount				Ratios (b)				Ratios (b)				Amount				Ratios (b)				Ratios (b)
Revenues		$	22,947								100.0			$	22,447								100.0
Provision for doubtful accounts			2,073												2,583
Cash revenues (a)			20,874				100.0								19,864				100.0
Salaries and benefits			9,282				44.5				40.4				8,880				44.7				39.6
Supplies			3,685				17.7				16.1				3,627				18.3				16.2
Other operating expenses			3,696				17.6				16.1				3,410				17.1				15.1
% changes from prior year:
Revenues			2.2	%
Cash revenues			5.1
Revenue per equivalent admission			1.3
Cash revenue per equivalent admission			4.2

HCA Inc.
Condensed Consolidated Balance Sheets
(Dollars in millions)

		September 30,				June 30,				December 31,
		2010				2010				2009
ASSETS
Current assets:
Cash and cash equivalents		$	377			$	350			$	312
Accounts receivable, net			3,636				3,769				3,692
Inventories			815				805				802
Deferred income taxes			1,045				1,126				1,192
Other			678				742				579
Total current assets			6,551				6,792				6,577
Property and equipment, at cost			25,226				24,950				24,669
Accumulated depreciation			(14,090	)			(13,798	)			(13,242	)
			11,136				11,152				11,427
Investments of insurance subsidiary			665				646				1,166
Investments in and advances to affiliates			857				870				853
Goodwill			2,610				2,583				2,577
Deferred loan costs			371				391				418
Other			1,063				986				1,113
		$	23,253			$	23,420			$	24,131
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable		$	1,254			$	1,179			$	1,460
Accrued salaries			1,007				927				849
Other accrued expenses			1,373				1,262				1,158
Long-term debt due within one year			696				1,029				846
Total current liabilities			4,330				4,397				4,313
Long-term debt			25,383				25,769				24,824
Professional liability risks			1,027				1,029				1,057
Income taxes and other liabilities			1,611				1,589				1,768
Total liabilities			32,351				32,784				31,962
Equity securities with contingent redemption rights			144				144				147
EQUITY (DEFICIT)
HCA Inc. stockholders’ deficit			(10,259	)			(10,525	)			(8,986	)
Noncontrolling interests			1,017				1,017				1,008
Total deficit			(9,242	)			(9,508	)			(7,978	)
		$	23,253			$	23,420			$	24,131

HCA Inc.
Condensed Consolidated Statements of Cash Flows
For the Nine Months Ended September 30, 2010 and 2009
(Dollars in millions)

		2010				2009
Cash flows from operating activities:
Net income		$	1,179			$	1,071
Adjustments to reconcile net income to net cash provided by operating activities:
Changes in operating assets and liabilities			(1,927	)			(2,136	)
Provision for doubtful accounts			2,073				2,583
Depreciation and amortization			1,062				1,067
Income taxes			(10	)			(485	)
Losses sales of facilities			2				8
Impairments of long-lived assets			119				16
Amortization of deferred loan costs			60				60
Share-based compensation			24				21
Pay-in-kind interest			—				58
Other			29				52
Net cash provided by operating activities			2,611				2,315
Cash flows from investing activities:
Purchase of property and equipment			(860	)			(915	)
Acquisition of hospitals and health care entities			(35	)			(42	)
Disposal of hospitals and health care entities			26				39
Change in investments			473				113
Other			(2	)			(2	)
Net cash used in investing activities			(398	)			(807	)
Cash flows from financing activities:
Issuance of long-term debt			1,387				2,979
Net change in revolving credit facilities			1,035				(1,125	)
Repayment of long-term debt			(2,020	)			(3,050	)
Distributions to noncontrolling interests			(282	)			(254	)
Payment of debt issuance costs			(25	)			(68	)
Payment of cash distributions to stockholders			(2,251	)			—
Other			8				(12	)
Net cash used in financing activities			(2,148	)			(1,530	)
Change in cash and cash equivalents			65				(22	)
Cash and cash equivalents at beginning of period			312				465
Cash and cash equivalents at end of period		$	377			$	443
Interest payments		$	1,399			$	1,154
Income tax payments, net		$	498			$	965

HCA Inc.
Operating Statistics

										For the Nine Months
		Third Quarter								Ended September 30,
		2010				2009				2010				2009
Consolidating Hospitals:
Number of Hospitals			154				155				154				155
Weighted Average Licensed Beds			38,645				38,829				38,646				38,819
Licensed Beds at End of Period			38,636				38,829				38,636				38,829
Reported:
Admissions			383,800				387,600				1,167,900				1,171,200
% Change			-1.0	%							-0.3	%
Equivalent Admissions			617,700				615,100				1,851,100				1,835,200
% Change			0.4	%							0.9	%
Revenue per Equivalent Admission		$	12,379			$	12,245			$	12,396			$	12,231
% Change			1.1	%							1.3	%
Inpatient Revenue per Admission		$	12,068			$	11,833			$	12,034			$	11,625
% Change			2.0	%							3.5	%
Patient Days			1,826,000				1,848,000				5,636,700				5,673,600
Equivalent Patient Days			2,939,900				2,934,100				8,934,100				8,890,500
Inpatient Surgery Cases			121,600				125,300				365,900				372,300
% Change			-3.0	%							-1.7	%
Outpatient Surgery Cases			194,100				199,100				583,400				593,700
% Change			-2.5	%							-1.7	%
Emergency Room Visits			1,457,100				1,441,200				4,260,400				4,198,900
% Change			1.1	%							1.5	%
Outpatient Revenues as a Percentage of Patient Revenues			38.3	%			38.1	%			37.7	%			38.3	%
Average Length of Stay			4.8				4.8				4.8				4.8
Occupancy			51.4	%			51.7	%			53.4	%			53.5	%
Equivalent Occupancy			82.8	%			82.1	%			84.6	%			83.8	%
Same Facility:
Admissions			381,300				383,800				1,160,300				1,160,400
% Change			-0.6	%							0.0	%
Equivalent Admissions			613,200				608,700				1,837,900				1,817,200
% Change			0.7	%							1.1	%
Revenue per Equivalent Admission		$	12,344			$	12,240			$	12,368			$	12,226
% Change			0.8	%							1.2	%
Inpatient Revenue per Admission		$	12,080			$	11,856			$	12,049			$	11,654
% Change			1.9	%							3.4	%
Inpatient Surgery Cases			121,000				124,300				363,400				369,700
% Change			-2.6	%							-1.7	%
Outpatient Surgery Cases			192,600				196,000				576,600				585,300
% Change			-1.8	%							-1.5	%
Emergency Room Visits			1,442,200				1,424,600				4,224,500				4,155,100
% Change			1.2	%							1.7	%
Number of Consolidating and Nonconsolidating (Equity Joint Ventures) Hospitals:
Consolidating			154				155				154				155
Nonconsolidating (Equity Joint Ventures)			8				8				8				8
Total Number of Hospitals			162				163				162				163